Recombinant human erythropoietin (Beijing Four Rings Bio-Pharmaceutical)
重组人促红素（北京四环生物制药）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human erythropoietin (Beijing Four Rings Bio-Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2000/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Four Rings Bio-Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Four Rings Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A